Surgery and radiation are well-known treatments for localized prostate cancer, but emerging options like HIFU, cryoablation, and NanoKnife are offering new hope. Dr. Andrew Wood of the Rogel Cancer Center explains how these focal therapies target only the cancerous tissue, reducing side effects such as incontinence and erectile dysfunction. While not every patient is a candidate, those with intermediate-risk, MRI-visible tumors may see meaningful benefits. Discover how this approach could transform prostate cancer care in the years ahead.
